Russell Investments Group, Ltd.
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1692234
Seattle, WA
Position in SLS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,051,279
+$975,115 QoQ
Shares Held
71,225
+295.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 192 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. SLS ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in SLS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,051,279 | 71,225 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $76,164 | 18,006 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $36,040 | 9,560 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,794 | 9,189 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||